Case study reveals potentially lethal side effects of lecanemab for treatment of Alzheimer's disease
by IOS PressThe most striking findings were the mononuclear attack on cerebral amyloid angiopathy (histiocytic vasculitis) with fibrinoid necrosis (left, Aβ immunohistochemistry [4G8]), and focal
Updated on: April 25,2024
10
Case study reveals potentially lethal side effects of lecanemab for treatment of Alzheimer's disease
by IOS PressThe most striking findings were the mononuclear attack on cerebral amyloid angiopathy (histiocytic vasculitis) with fibrinoid necrosis (left, Aβ immunohistochemistry [4G8]), and focal
Updated on:April 25,2024
10